Skip to content

Rocket Lab USA, Inc. RKLB Concentration Risk %

Concentration Risk % at other companies

Gyre Therapeutics, Inc. logo
Gyre Therapeutics, Inc.GYRE
93.1%-5.3pp
Heartland Express logo
Heartland ExpressHTLD
32%+6.0pp
Enovix Corporation logo
Enovix CorporationENVX
83%+36.0pp
Weis Markets logo
Weis MarketsWMK
100%0.0pp
Innoviva, Inc. logo
Innoviva, Inc.INVA
36%+7.0pp
Strattec Security logo
Strattec SecuritySTRT
0.5%0.0pp

Segments

By geography

See full
Rest of world7%-12.5%

Other financials

Income statement

See full
Revenue$200.3M+63.5%
Gross profit$76.5M+117%
Operating income-$56.0M+5.4%
Net income-$45.0M+25.7%
EPS (diluted)-$0.07+41.7%

Balance sheet

See full
Cash & equivalents$1.2B+293%
Total debt$101.8M-29.2%
Total equity$2.3B+425%
Total assets$2.8B+125%

Cash flow

See full
Operating cash flow-$50.3M+7.2%
CapEx$27.1M-5.6%
Free cash flow-$77.4M+6.6%

Valuation

See full
Market cap$50.42B+264%
Enterprise value$49.31B+260%
P/S74.2×+44.4×

Profitability

See full
Gross margin36.6%+9.3pp
Operating margin-33.2%-6.6pp
Net margin-26.9%-7.6pp
FCF margin-46.5%+13.5pp

Returns & leverage

See full
Return on equity-13.5%-5.6pp
Debt / equity-0.3×
Current ratio4.5×+2.4×